ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma

• NASDAQ: $ADMA
• Notified: $2.50
• 07:01 EDT